Intravenous Immunoglobulin Market: Harnessing Growth Through Advancements in Plasma Fractionation & Rising Geriatric Population

The surging demand for better treatment methods for primary immunodeficiency disorders, neurological diseases, pediatric disorders, and other applications continues to fuel the expansion of the intravenous immunoglobulin market.

What Is The Projected Market Size Of The Global Intravenous Immunoglobulin Market And Its Growth Rate?
• The market is expected to grow from $14.66 billion in 2024 to $15.72 billion in 2025, emphasizing a CAGR of 7.2%.
• The rise of the intravenous immunoglobulin market over the years is credited to developments in plasma fractionation techniques, management of neurological disorders, increasing elderly population, and treatment for primary immunodeficiency disorders.
• By 2029, the market is poised to reach $22.01 billion, underpinned by a CAGR of 8.8%. The growth can be attributed to several factors such as ongoing immunology research, advancements in immunoglobulin products, a surge in healthcare expenditure, and the burgeoning incidence of autoimmune disorders and cancer.

What Is Driving The Growth In The Intravenous Immunoglobulin Market?
The rising geriatric population is a significant contributor to the growing demand for intravenous immunoglobulin. People above the age of 65 often experience a drop in immunity, leading to a pronounced need for antibodies supplied by immunoglobulins. To illustrate, projections by the Population Reference Bureau suggest a 47% increase in the population of Americans aged 65 and over, from 58 million in 2022 to 82 million by 2050. As the geriatric population's share climbs to 23% from the current 17% by 2050, the increasing need for intravenous immunoglobulin to supplement reduced immunity among the elderly will visibly drive the market.

Request A Free Sample Copy:
https://www.thebusinessresearchcompany.com/sample.aspx?id=8538&type=smp

Who Are the Key Players Driving Intravenous Immunoglobulin Market Growth?
The key players propelling the market growth include:
• Bio Products Laboratory Limited
• Biotest AG
• China Biologic Products Holdings Inc.
• CSL Behring
• Grifols S.A.
• Kedrion Spa
• Shanghai RAAS Blood Products Co. Ltd.
• Octapharma AG
• Takeda Pharmaceutical Company Limited
• Baxter International Inc.

What Are The Key Trends In The Intravenous Immunoglobulin Market?
Trends playing a role in shaping the market:
• Treatment of primary immunodeficiency disorders (PIDD)
• Rapid innovations in technology
• Partnerships and collaborations in strategic planning
• Advances in manufacturing processes
• Applications in neurology and hematology
• Innovations in immunotherapy.

What Are The Segments Of The Global Intravenous Immunoglobulin Market?
The global market is categorized as per:
1) Type: IgG, IgM, IgA, IgE, IgD
2) Distribution Channel: Hospital Pharmacy, Retail Pharmacy, Other Distribution Channels
3) Application: Hypogammaglobulinemia, CIDP, Primary Immunodeficiency Diseases, Myasthenia Gravis, Multifocal Motor Neuropathy, Other Applications
4) End-User: Hospitals, Clinics, Home Care

Which Region Leads The Intravenous Immunoglobulin Market?
North America dominated the intravenous immunoglobulin market in 2024, with the Asia-Pacific region following closely as the fastest-growing region in the forecast period. The market scope encompasses regions such as the Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, and Africa.

Pre-book the Report for Swift Delivery:
https://www.thebusinessresearchcompany.com/report/intravenous-immunoglobulin-global-market-report

What Is Covered In The Intravenous Immunoglobulin Market Global Market Report?
- Market Size Analysis: Analyze the Intravenous Immunoglobulin Market size by key regions, countries, product types, and applications.

- Market Segmentation Analysis: Identify various subsegments within the Intravenous Immunoglobulin Market for effective categorization.

- Key Player Focus on key players to define their market value, share, and competitive landscape.

- Growth Trends Analysis: Examine individual growth trends and prospects in the Market.

- Market Contribution: Evaluate contributions of different segments to the overall Intravenous Immunoglobulin Market growth.

- Growth Drivers: Detail key factors influencing market growth, including opportunities and drivers.

- Industry Challenges: Analyze challenges and risks affecting the Intravenous Immunoglobulin Market.

- Competitive Developments: Analyze competitive developments, such as expansions, agreements, and new product launches in the market.

Contact Us:
The Business Research Company
Europe: +44 207 1930 708
Asia: +91 88972 63534
Americas: +1 315 623 0293
Email: info@tbrc.info

Follow Us On:
LinkedIn: https://in.linkedin.com/company/the-business-research-company
Twitter: https://twitter.com/tbrc_info
YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ

Learn More About the Business Research Company.
With over 15,000+ reports from 27 industries covering 60+ geographies, The Business Research Company has built a reputation for offering comprehensive, data-rich research and insights. Armed with 1,500,000 datasets, the optimistic contribution of in-depth secondary research, and unique insights from industry leaders, you can get the information you need to stay ahead.
Our flagship product, the Global Market Model (GMM), is a premier market intelligence platform delivering comprehensive and updated forecasts to support informed decision-making.

This release was published on openPR.